Abstract:Background Glutamate-cysteine ligase modifier (GCLM) subunits, combined with catalytic (GCLC) subunits, has been known for the first rate-limiting enzyme for glutathione (GSH) synthesis. Increasing studies have shown that the non-metabolic functions of many metabolic enzymes also play a crucial role in tumor progress. However, the non-metabolic functions of GCLM remain unexplored. Hence, we wonder if there are unorthodox functions of GCLM under redox stress participating colorectal Carcinoma(CRC) tumorigenesis. Methods Western blot, real-time quantitative PCR and immunohistochemical analysis were used to detect the relative expression of GCLM in cell lines and patients‘ specimens. The MTS assay, migration and invasion assay, sphere formation assay were performed to detect the functions of GCLM in vitro, and the xenograft models and PDX models in nude mice in vivo. Cytosolic and nuclear extraction, immunofluorescent analysis were used to show the location of GCLM. Chromatin immunoprecipitation (ChIP) assay was used to screen and verify the GCLM target genes. Results We found that glucose deprivation condition upregulated the expression of GCLM rather than hypoxia or H2O2. Compared to adjacent tumor tissues, the expression of GCLM was upregulated in CRC tumor tissues. The high expression of GCLM predicted poor prognosis in CRC patients. Inhibition of GCLM results in decreased proliferation rate, migration and invasion ability and sphere formation in HCT116 and DLD1 in vitro. Similarly, GCLM inhibition suppressed CRC tumorigenesis and metastasis in xenograft models and PDX models in vivo. The cancer cell stem cell markers were also downregulated after GCLM inhibition. Interestingly, we found that glucose starvation could rescue the anti-cancer phenotypes of GCLM inhibition and led to nucleus-translocation and accumulation of GCLM. ChIP assay showed GCLM could interact with octamer-binding transcription factor 4 (OCT4) promoter, a cancer stem cell marker, to increase its expression, and the target gene of OCT4 showed a positive correlation with GCLM expression in CRC patients. Conclusions Our data showed that GCLM displayed nucleus accumulation in the condition of glucose deprivation which increased the transcription of OCT4. This study revealed an unorthodox oncogenic function of GCLM in colorectal carcinoma and suggested GCLM as a potential therapeutic target in CRC.

LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc

Abstract 2389: LINC00901 Regulates Glucose Metabolism in Pancreatic Cancer

Linc00901 Regulates Glucose Metabolism In Pancreatic Cancer.

Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1

LncRNA MIR17HG Promotes Colorectal Cancer Liver Metastasis by Mediating a Glycolysis-Associated Positive Feedback Circuit

Long Noncoding RNA AGPG Regulates PFKFB3-mediated Tumor Glycolytic Reprogramming

Loss of MiR-192-5p Initiates a Hyperglycolysis and Stemness Positive Feedback in Hepatocellular Carcinoma.

MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration

The Long Noncoding RNA LUCAT1 Promotes Cell Proliferation Via Binding with NCL and Regulating MYC Expression in Colorectal Cancer

The Long Noncoding RNA LUCAT1 Promotes Colorectal Cancer Cell Proliferation by Antagonizing Nucleolin to Regulate MYC Expression

C-Myc-activated Long Noncoding RNA CCAT1 Promotes Colon Cancer Cell Proliferation and Invasion

Role of Long Non-Coding RNAs in Glucose Metabolism in Cancer.

N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming

The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma

LncRNA XLOC_006390 promotes pancreatic carcinogenesis and glutamate metabolism by stabilizing c-Myc.

CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer

Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

IDDF2019-ABS-0292 Nucleus-translocated GCLM Facilitates Tumor Progression Through Increasing Transcription of OCT4 in Colorectal Carcinoma

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway